This Biotech June Catalyst: What Investors Need to Know Now
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
BTC vs ETH fundamentals: a side-by-side look at core strengths and weaknesses to inform your next move.
27,640 articlesA major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
The AI IPO race is accelerating as OpenAI joins the fray after Anthropic. This article breaks down what the filing me...
FuelCell Energy surges on a major data-center deal, while Bloom Energy retreats, underscoring a rare divergence in th...
Quantum investing is no longer a dream. This practical guide weighs D-Wave Quantum’s potential, the risks, and steps ...
Palantir is navigating a mix of headwinds and catalysts as 2026 unfolds. Here are three grounded predictions palantir...
A single, time-tested rule guides smart stock selection: buy high-quality businesses at fair prices. Here are three s...
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Hyperliquid has cooled after a brief rally, with the HYPE token trading near $62 as traders warn of a deeper pullback...
Dogecoin fell to a three-year low around $0.072, triggering a buy-signal read from a key indicator. Traders are split...
A value-driven, catalyst-led small-cap approach is drawing attention as investors seek mispriced names with clear ups...
A caller on The Ramsey Show turned $270K into $1.1M in three years, driven by four stock bets. Ramsey cautions that s...
Bitcoin built on recent gains as macro risk appetite improved and liquidity returned, setting the stage for a test of...